Clinical & Translational Immunology

Papers
(The TQCC of Clinical & Translational Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
46
44
SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system30
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis28
Characteristics of PD‐1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients26
Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant25
An optimised whole blood interleukin‐2 release assay is more sensitive than interferon‐γ ELIS pot for detecting and quantifying gluten‐specific 24
Spatial omics for profiling the dynamic tumor microenvironment24
The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4‐related disease21
Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation20
17
Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID‐1917
High IL ‐10 levels during CRS are negatively associated with NK 17
15
15
Targeting BMI‐1 to deplete antibody‐secreting cells in autoimmunity14
Adeno‐associated viral vectors encoding anti‐P2X7 nanobodies reduce graft‐versus‐host disease in a humanised mouse model14
Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma14
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease13
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation13
Effects of extremely preterm birth on cytokine and chemokine responses induced by T‐cell activation during infancy13
Optimised modular anti‐FLAG CAR T cells for solid tumor therapy12
Genome‐wide association study and polygenic risk scores of eosinophilia in Taiwan12
Inhibitory effect of hydroxychloroquine on glucocorticoid‐induced osteoporosis in lupus therapy12
12
Siglec‐1, an easy and contributory inflammation marker in rheumatology11
Immunological insights into gastric polyps: pathogenesis, inflammation and neoplastic potential11
Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models10
10
Naturally acquired adaptive immunity to Streptococcus pneumoniae is impaired in rheumatoid arthritis patients10
10
Alterations of circulating innate lymphoid cells in recent‐onset type 1 diabetes10
Adaptive immune response to the autoantigen LL ‐37 differentiates atherosclerotic cardiovascular disease phenotypes10
10
High KRT17 expression in tumour budding indicates immunologically ‘hot’ tumour budding and predicts good survival in patients with colorectal cancer10
Human axillary lymph node T follicular helper (Tfh) and Precursor‐Tfh cells exhibit functional flexibility following seasonal influenza vaccination9
Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity9
Fatty acid metabolism—an emerging regulatory node in T‐cell immunometabolism9
9
Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis9
Skin immunity and inflammation: cellular interactions and communication9
8
Data standards for single‐cell RNA‐sequencing of paediatric cancer8
Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort8
8
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies8
7
Pulmonary complications post allogeneic haematopoietic stem cell transplant in children7
Helminths as architects of trained tolerance: implications for human health7
The impact of B‐cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients7
Hypoxia‐inducible factor‐1α regulates the interleukin‐6 production by B cells in rheumatoid arthritis7
A novel case of autosomal recessive CARD11 loss‐of‐function underlying impaired antiviral immunity and a review of literature7
Neutralising antibody responses to emerging SARSCoV ‐2 omicron sub‐variants are enhanced in per7
CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer7
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients6
Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis6
Spatial proteomic profiling of tumor and stromal compartments in non‐small‐cell lung cancer identifies signatures associated with overall survival6
6
A unique cytotoxic CD4 + T cell‐signature defines critical COVID‐196
Multi‐omics integration reveals a nonlinear signature that precedes progression of lung fibrosis6
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis6
A comprehensive analysis of the correlation between plasma cytokines/chemokines and tumor immune microenvironment signature influences the response of checkpoint inhibitors in advanced non‐small‐cell 6
Long‐term effects of influenza and Bacille Calmette–Guérin vaccination on systemic inflammation6
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis6
0.11021399497986